Safety and risk management in clinical trials for chronic wounds with tissue regenerative products. [PDF]
Malikova MA +3 more
europepmc +1 more source
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Clinical efficacy of vestibular incision subperiosteal tunnel access (VISTA) for the treatment of gingival recession: a systematic review and meta-analysis. [PDF]
Zhu Q, Sun F, Gao Y, Wang J, Zhou Y.
europepmc +1 more source
Performance, carcass, haematology and blood chemistry of broilers fed on cooked wild cocoyam [ Colocasia esculenta (L.) Schott] corms as partial substitutes for maize [PDF]
Rotimi Olajide, AO Akinsoyinu
openalex
Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen +11 more
wiley +1 more source
Improving sapropterin administration efficacy in PKU: Clinical practice case studies. [PDF]
Tosi M +7 more
europepmc +1 more source
Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte +13 more
wiley +1 more source
Effect of photobiomodulation with isolated or combined use of red and infrared lasers on repair of sites grafted with deproteinized bovine bone. [PDF]
Pereira LSG +5 more
europepmc +1 more source

